Trial intelligence / Profile preview

Dexmedetomidine and Morphine as Adjuvants to ESPB in Thoracic Surgery

NCT05843344Unknown

Start
May 2023
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of morphine and dexmedetomidine in postoperative pain and chronic pain (3 arms). Primary endpoint: Intravenous morphine consumption in the first 48 hours post-operatively. Status: unknown.

02

Drugs

morphinedexmedetomidine
03

Conditions

postoperative painchronic pain

Beyond the preview

Go deeper on NCT05843344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05843344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call